Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Pharma
AstraZeneca says vaccine 76% effective for 90 days after single dose
Life Sciences Times
-
February 3, 2021
0
Pharma
Daiichi Sankyo Initiates Clinical Development of Sixth DXd ADC DS-6000 with Sarah Cannon Research Institute
Life Sciences Times
-
February 2, 2021
0
Life Sciences
Gilead and the Human Rights Campaign Will Work Together to Combat HIV Epidemic and Promote Transgender Justice
Life Sciences Times
-
February 2, 2021
0
Venture Capital
Oxford Finance Provides $47 Million Credit Facility to Averhealth
Life Sciences Times
-
February 2, 2021
0
Biotech
Glympse Bio Names Jessica Atkinson Senior Vice President of Business Development
Life Sciences Times
-
February 2, 2021
0
Biotech
New England Biolabs and Color Partner to Provide COVID-19 Testing to Biotech Workers Essential to Global Pandemic Response
Life Sciences Times
-
February 2, 2021
0
Medtech
Dr. Siddhartha Kadia to Join NuVasive Board of Directors
Life Sciences Times
-
February 2, 2021
0
Life Sciences
Life Biosciences appoints Joan Mannick, MD, to lead its research and development
Life Sciences Times
-
February 2, 2021
0
Life Sciences
MYND Life Sciences Announces Research Agreement with the University of British Columbia on Major Depressive Disorder
Life Sciences Times
-
February 2, 2021
0
Public Health
Bleeding gums may indicate vitamin C deficiency
Life Sciences Times
-
February 2, 2021
0
1
...
783
784
785
...
805
Page 784 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026